Aradigm Corp Bearish Trade. Jean’s First Eagle Investment Management decreased Its Position

April 17, 2018 - By Linda Rogers

Investors sentiment increased to 3 in 2017 Q4. Its up 2.14, from 0.86 in 2017Q3. It is positive, as 2 investors sold Aradigm Corporation shares while 1 reduced holdings. 5 funds opened positions while 4 raised stakes. 4.54 million shares or 4.27% more from 4.35 million shares in 2017Q3 were reported.

Blackrock holds 0% in Aradigm Corporation (NASDAQ:ARDM) or 4,342 shares. Bancorp Of Ny Mellon holds 22,220 shares or 0% of its portfolio. Royal Bancorp Of Canada holds 507 shares or 0% of its portfolio. Fmr Ltd Liability Corp accumulated 168,740 shares or 0% of the stock. New York-based Evercore Wealth Mngmt Ltd Liability Corp has invested 0% in Aradigm Corporation (NASDAQ:ARDM). First Eagle Mgmt Ltd Limited Liability Company reported 3.85M shares. Moreover, Vanguard Gru Incorporated has 0% invested in Aradigm Corporation (NASDAQ:ARDM) for 361,998 shares. Geode Mngmt Ltd holds 0% or 63,010 shares. Deutsche National Bank Ag reported 7 shares. Northern Corporation has 25,701 shares. 67 are owned by Tower Rech Cap Ltd Llc (Trc). Morgan Stanley holds 0% in Aradigm Corporation (NASDAQ:ARDM) or 18,216 shares. Spark Management Llc reported 13,000 shares stake. Focused Wealth owns 0% invested in Aradigm Corporation (NASDAQ:ARDM) for 2 shares.

Since January 29, 2018, it had 0 insider purchases, and 1 sale for $26,027 activity.

Jean’s First Eagle Investment Management Reported reduced Stake in Aradigm Corp

First Eagle Investment Management filed with SEC a SC 13D/A form for Aradigm Corp. It can be found at: 000089914018000343. As reported by Jean’s First Eagle Investment Management, the filler decreased its stake in the stock by -11.39 % for 4,210,186 shares. Jean’s First Eagle Investment Management currently owns 26.31% of the Health Care- stock. Date of activity: April 13, 2018.

The hedge fund with about $102.00 billion looks more negative after reporting such a decrease of its Aradigm Corp ownership.

The hedge fund is investor in the Health Care sector.

Aradigm Corp Institutional Sentiment

Filings show 12 investors own Aradigm Corp. The ownership in Q3 2017 is low, at Infinity of the outstanding shares. This is increased by 527689. 4354609 were owned by these investors. 4 funds opened new Aradigm Corp stakes, 2 increased positions. There were 4 that closed positions and 3 reduced them.

Fmr Llc is an investor bullish on Aradigm Corp, owning 168740 shares as of Q3 2017 for less than 0.01% of its portfolio. Virtu Financial Llc owns 25862 shares or less than 0.01% of its portfolio. NY Focused Wealth Management Inc have less than 0.01% of its portfolio for 2 shares. Further, Evercore Wealth Management Llc reported stake worth less than 0.01% of its portfolio. The NY First Eagle Investment Management Llc owns 3854730 shares. Aradigm Corp is 0.04% of its portfolio.

SEC Form 13D.

Jean’s First Eagle Investment Management website.

The stock increased 20.89% or $0.33 during the last trading session, reaching $1.91. About 906,360 shares traded or 131.45% up from the average. Aradigm Corporation (NASDAQ:ARDM) has declined 25.73% since April 18, 2017 and is downtrending. It has underperformed by 37.28% the S&P500.

Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of drugs for the prevention and treatment of severe respiratory diseases. The company has market cap of $27.80 million. The company's lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin (ARD-3100) that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis and cystic fibrosis. It currently has negative earnings. It is also developing inhaled ciprofloxacin formulations for treatment of patients with cystic fibrosis and non-tuberculous mycobacteria, as well as the prevention and treatment of high threat and bioterrorism infections, such as inhaled tularemia, pneumonic plague, melioidosis, Q fever, and inhaled anthrax.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.